Lansing, Mich.
Emergent BioSolutions was awarded a contract by the Department of Health and Human Services to expand anthrax vaccine production at its facility in Lansing, Mich. The contract was awarded by the Office of the Biomedical Advanced Research and Development Authority and will increase manufacturing capacity to 26 million doses per year. The value of the contract is estimated at $107 million over five years.
